echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > In order to consolidate the control of state-owned assets, China Resources increased its holdings of Dong Agu by 1.5 billion yuan.

    In order to consolidate the control of state-owned assets, China Resources increased its holdings of Dong Agu by 1.5 billion yuan.

    • Last Update: 2020-06-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Medicine son, February 4th, just after the Spring Festival, February 3rd, the listed company's East A-glue majority shareholder China Resources again shot, spending 1.5 billion yuan to increase its holdings on Dong'a gum, compared with the background of the previous "entry" of a number of risk capital, China Resources said the move is to consolidate the state-owned shareholders for its listed companies control and decision-making powerincreased its holdings of
    32.71 million shares, accounting for 5% of the company's total share capital
    listed company Dong Agu issued a notice that the company received China ResourcesPharmaceuticalInvestment Co., Ltd(hereinafter referred to as "China Resources Pharmaceutical Investment"), China Resources East Agar Co., Ltd(hereinafter referred to as "China Resources" Donga's notice that China Resources Pharma invested in the company's shares by 32.71 million shares, or 5% of the company's total share capital, through the Shenzhen Stock Exchange's centralized bidding trading system from April 20, 2016 to January 25, 2017based on the stock price range of 43.99-55.00 yuan at the time of china resources pharmaceutical investment, China Resources Pharmaceutical investment will cost 1.5 billion yuanaccording to the announcement, before this round of increases, China Resources Pharmaceutical Investment did not hold shares of listed companies, and its concerted action person China Resources East A holds 151 million shares of listed companies, accounting for 23.14% of the total share capital of listed companies, the largest shareholder of listed companiesand the increase in the amount of chips, China Resources Pharmaceutical Investment and its co-acting person, China Resources East Asia A total of 184 million shares of listed companies, accounting for 28.14% of the total share capital of listed companies, close to 30% of the offer to buy the red lineand risk capital staged "attack and defense war"before the increase, around the listed company platform East Agum, the majority shareholder China Resources has been with the opportunity to enter the risk of the "attack and defense war."early 2016, "Baoeng" insurance capital Qianhai Life through its products Haili year after year into The East Agum, and quickly rushed to raise funds, the shareholding ratio once exceeded 4.1%, close to 5% of the brand lineChina Resources followed suit, buying 30,476.1 million shares of Dong'agum, or 4.66 percent of the total share capital, as of the second quarter of 2016After , Qianhai Life reduced its stake to 1.14 per cent and made a profit As of the third quarter of last year, the list of the top 10 shareholders in Dong'agum has also appeared in the list of insurance funds, including Pacific Life and Anbang Insurance China Resources this round of increased holdings has also been interpreted by the market as a counterweight to these "uninvited visitors" in a detailed report on changes in equity, China Resources Pharmaceutical Investment stressed the importance of "state-owned holding", saying that the increase is aimed at "based on the ability to consolidate the control and decision-making power of state-owned shareholders on its listed companies .. To boost confidence in capital markets and to preserve and increase the value of state-owned assets and shareholders At the same time, it did not rule out the possibility of further increases with concerted action in the next 12 months
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.